Inmed Pharmaceuticals logo

Inmed Pharmaceuticals Share Price Today

(NASDAQ: INM)

Inmed Pharmaceuticals share price is $2.69 & ₹233.95 as on 6 Mar 2025, 2.30 'hrs' IST

$2.69

0.04

(1.7%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Inmed Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Inmed Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Inmed Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Inmed Pharmaceuticals share price movements

  • Today's Low: $2.53
    Today's High: $2.90

    Day's Volatility :12.67%

  • 52 Weeks Low: $2.41
    52 Weeks High: $15.70

    52 Weeks Volatility :84.62%

Inmed Pharmaceuticals (INM) Returns

PeriodInmed Pharmaceuticals IncNifty Smallcap 250
3 Months
-51.2%
-21.6%
6 Months
-51.77%
-22.7%
1 Year
-63.27%
-4.6%
3 Years
-99.32%
62.3%

Inmed Pharmaceuticals (INM) Key Statistics

in dollars & INR

Previous Close
$2.645
Open
$2.65
Today's High
$2.9
Today's Low
$2.5325
Market Capitalization
$3.4M
Today's Volume
$11.7K
52 Week High
$15.696
52 Week Low
$2.414
Revenue TTM
$4.8M
EBITDA
$-7.5M
Earnings Per Share (EPS)
$-12.42
Profit Margin
-163.77%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-83.5%

How to invest in Inmed Pharmaceuticals Stock (INM) from India?

It is very easy for Indian residents to invest directly in Inmed Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Inmed Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Inmed Pharmaceuticals or INM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Inmed Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Inmed Pharmaceuticals shares which would translate to 0.323 fractional shares of Inmed Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Inmed Pharmaceuticals, in just a few clicks!

Returns in Inmed Pharmaceuticals (INM) for Indian investors in Rupees

The Inmed Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Inmed Pharmaceuticals investment value today

Current value as on today

₹42,324

Returns

₹57,676

(-57.68%)

Returns from Inmed Pharmaceuticals Stock

₹62,639 (-62.64%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Inmed Pharmaceuticals (INM)

-41%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Inmed Pharmaceuticals Stock from India on INDmoney has decreased by -41% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Inmed Pharmaceuticals

  • AdvisorShares Investments, LLC

    3.19%

  • UBS Group AG

    0.86%

Analyst Recommendation on Inmed Pharmaceuticals

Sell

    0%Buy

    37%Hold

    62%Sell

Based on 8 Wall street analysts offering stock ratings for Inmed Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
0
0
0
Hold
3
3
3
Sell
5
5
5

Analyst Forecast on Inmed Pharmaceuticals Stock (INM)

What analysts predicted

Upside of 643.49%

Target:

$20.00

Current:

$2.69

Insights on Inmed Pharmaceuticals Stock (Ticker Symbol: INM)

  • Price Movement

    In the last 3 months, INM stock has moved down by -4.2%
  • Price Movement

    In the last 3 months, INM stock has moved down by -51.2%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 1.26M → 1.11B (in $), with an average increase of 99.9% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 5 quarters, -1.47M → -2.57B (in $), with an average decrease of 21643.6% per quarter
  • INM vs - (1 yr)

    In the last 1 year, Intra-cellular Therapies, Inc. has given 97.0% return, outperforming this stock by 160.6%
  • INM vs - (3 yr)

    In the last 3 years, Intra-cellular Therapies, Inc. has given 138.2% return, outperforming this stock by 237.6%
  • Price to Sales

    ForINM every $1 of sales, investors are willing to pay $0.3, whereas for Intra-cellular Therapies, Inc., the investors are paying $19.9 for every $1 of sales.

Inmed Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Inmed Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Inmed Pharmaceuticals (INM) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Inmed Pharmaceuticals Inc logo
-13.84%
-51.77%
-63.27%
-99.32%
-99.84%
Intra-cellular Therapies, Inc. logo
3.42%
81.22%
98.76%
146.55%
588.92%
Haleon Plc Spon Ads logo
12.55%
3.39%
28.09%
43.99%
43.99%
Zoetis Inc. logo
-1.19%
-8.94%
-7.43%
-9.67%
30.97%
Neurocrine Biosciences Inc. logo
-24.64%
-6.68%
-14.47%
28.61%
27.88%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Inmed Pharmaceuticals Inc logo
0.01
NA
NA
0.0
-0.83
-0.41
NA
8.54
Intra-cellular Therapies, Inc. logo
NA
NA
0.0
0.13
-0.09
-0.07
NA
10.81
Haleon Plc Spon Ads logo
26.68
26.68
1.5
0.36
0.09
0.04
0.02
1.8
Zoetis Inc. logo
31.17
31.17
3.01
6.07
0.51
0.15
0.01
10.64
Neurocrine Biosciences Inc. logo
34.8
34.8
0.27
6.47
0.14
0.1
NA
26.05
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Inmed Pharmaceuticals Inc logo
Sell
$3.4M
-99.84%
0.01
-163.77%
Intra-cellular Therapies, Inc. logo
Buy
$14.0B
588.92%
NA
-10.97%
Haleon Plc Spon Ads logo
Buy
$48.2B
43.99%
26.68
12.84%
Zoetis Inc. logo
Buy
$76.1B
30.97%
31.17
26.86%
Neurocrine Biosciences Inc. logo
Buy
$11.3B
27.88%
34.8
14.49%

About Inmed Pharmaceuticals

InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, develops a pipeline of prescription-based products in the United States. It operates through two segments: InMed Pharma and BayMedica Commercial. The InMed Pharma segment researches and develops cannabinoid-based pharmaceuticals products. The BayMedica Commercial segment develops proprietary manufacturing technologies to produce and sell rare cannabinoids for the health and wellness industry. Its prescription-based products include rare cannabinoids and novel cannabinoid analogs for the treatment of diseases with high unmet medical needs. The company's lead product is INM-755, a cannabinol topical skin cream, completed Phase 2 clinical trial for the treatment of epidermolysis bullosa. It also develops INM-089, which is a small molecule compound acting as a selective dual CB1 /CB2 agonist; and INM-900 for neurodegenerative diseases. In addition, the company offers IntegraSyn, an integrated biosynthesis-based manufacturing approach, for pharmaceutical-grade cannabinoids; and cannabichromene, cannabicitran, cannabidivarin, and tetrahydrocannabivarin. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada.
Organization
Inmed Pharmaceuticals
Employees
13
CEO
Mr. Eric A. Adams B.S. Chem., M.I.B.
Industry
Health Technology

Management People of Inmed Pharmaceuticals

NameTitle
Mr. Eric A. Adams B.S. Chem., M.I.B.
President, CEO & Director
Ms. N. Netta Jagpal
CFO & Corporate Secretary
Mr. Michael Woudenberg P.Eng.
Chief Operating Officer
Ms. Alexandra Diane-Janet Mancini M.Sc.
Senior Vice President of Clinical & Regulatory Affairs
Dr. Eric Chih-Hsien Hsu Ph.D.
Senior Vice President of Preclinical Research & Development
Dr. Sazzad Hossain M.Sc., Ph.D.
Co-Founder
Colin Clancy
Senior Director of Investor Relations
Mr. Jerry P. Griffin
Vice President of Sales & Marketing
Dr. Shane A. Johnson Ph.D.
Senior VP & GM of BayMedica
Dr. Ado Muhammad
Senior Consultant of Medical Affairs

Important FAQs about investing in INM Stock from India :

What is Inmed Pharmaceuticals share price today?

Inmed Pharmaceuticals share price today stands at $2.69, Open: $2.65 ; Previous Close: $2.65 ; High: $2.90 ; Low: $2.53 ; 52 Week High: $15.70 ; 52 Week Low: $2.41.

The stock opens at $2.65, after a previous close of $2.65. The stock reached a daily high of $2.90 and a low of $2.53, with a 52-week high of $15.70 and a 52-week low of $2.41.

Can Indians buy Inmed Pharmaceuticals shares?

Yes, Indians can invest in the Inmed Pharmaceuticals (INM) from India.

With INDmoney, you can buy Inmed Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Inmed Pharmaceuticals at zero transaction cost.

How can I buy Inmed Pharmaceuticals shares from India?

It is very easy to buy Inmed Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Inmed Pharmaceuticals (INM) be purchased?

Yes, you can buy fractional shares of Inmed Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Inmed Pharmaceuticals stocks?

To start investing in Inmed Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Inmed Pharmaceuticals Stock (INM)?

Today’s highest price of Inmed Pharmaceuticals (INM) is $2.90.

Today’s lowest price of Inmed Pharmaceuticals (INM) is $2.53.

What is today's market capitalisation of Inmed Pharmaceuticals?

Today's market capitalisation of Inmed Pharmaceuticals INM is 3.4M

What is the 52 Week High and Low Range of Inmed Pharmaceuticals Stock (INM)?

  • 52 Week High

    $15.70

  • 52 Week Low

    $2.41

What are the historical returns of Inmed Pharmaceuticals (INM)?

  • 1 Month Returns

    -13.84%

  • 3 Months Returns

    -51.77%

  • 1 Year Returns

    -63.27%

  • 5 Years Returns

    -99.84%

Who is the Chief Executive Officer (CEO) of Inmed Pharmaceuticals ?

Mr. Eric A. Adams B.S. Chem., M.I.B. is the current Chief Executive Officer (CEO) of Inmed Pharmaceuticals.